Prognostic influence of p53 nuclear overexpression in colorectal carcinoma

被引：11

作者：

Gallego, MG ^{[1
]}

Aceñero, MJF

Ortega, JS

Delgado, AA

Balibrea Cantero, JL

机构：

[1] Hosp de la Fuenfria, Cercedilla, Spain

[2] Hosp Mostoles, Dept Surg Pathol, Madrid, Spain

[3] Hosp Clin Madrid, Dept Surg Pathol, Madrid, Spain

[4] Hosp Clin Madrid, Dept Surg, Madrid, Spain

来源：

DISEASES OF THE COLON & RECTUM | 2000年 / 43卷 / 07期

关键词：

colorectal carcinoma; p53; prognosticators;

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

PURPOSE: The aim of this study was to test the prognostic influence of p53 nuclear overexpression in colorectal carcinoma. METHODS: We performed an analysis of the prognostic influence of the nuclear overexpression of p53 with immunohistochemistry in 126 cases of colorectal carcinoma operated on in our hospital between 1987 and 1992, with a minimum follow-up time of 60 months (5 years). RESULTS: Our results show a statistically significant prognostic influence of p53 overexpression on disease-free survival time, but not on the overall survival time, in univariate analysis, but this influence is lost in multivariate analysis. CONCLUSIONS: Our results confirm recent reports by other authors that failed to show the independent prognostic value of p53 in colorectal carcinoma.

引用

页码：971 / 975

页数：5

共 40 条

[1] Prognostic Significance of Tumor Markers in Colorectal Cancer Patients: DNA Index, S-Phase Fraction, p53 Expression, and Ki-67 Index [J].

Chen Y.-T. ;

Henk M.J. ;

Carney K.-J. ;

Wong W.D. ;

Rothenberger D.A. ;

Zheng T. ;

Feygin M. ;

Madoff R.D. .

Journal of Gastrointestinal Surgery, 1997, 1 (3) :266-273

[2]

DEVITA VT, 1993, CANC PRINCIPLES PRAC, P923

[3]

EBINA M, 1994, CANCER RES, V54, P2496

[4]

Fernandez Acenero M. J., 1998, Journal of Clinical Oncology, V16, P1684

[5] Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer. An immunohistochemical analysis [J].

Flamini, G ;

Curigliano, G ;

Ratto, C ;

Astone, A ;

Ferretti, G ;

Nucera, P ;

Sofo, L ;

Sgambato, A ;

Boninsegna, A ;

Crucitti, F ;

Cittadini, A .

EUROPEAN JOURNAL OF CANCER, 1996, 32A (05) :802-806

[6] P53 EXPRESSION IN EPITHELIAL OVARIAN NEOPLASMS - RELATIONSHIP TO CLINICAL AND PATHOLOGICAL PARAMETERS, KI-67 EXPRESSION AND FLOW-CYTOMETRY [J].

HENRIKSEN, R ;

STRANG, P ;

WILANDER, E ;

BACKSTROM, T ;

TRIBUKAIT, B ;

OBERG, K .

GYNECOLOGIC ONCOLOGY, 1994, 53 (03) :301-306

[7]

ITO K, 1994, CANCER RES, V54, P4667

[8] THE PROGNOSTIC-SIGNIFICANCE OF THE ACCUMULATION OF P53 TUMOR-SUPPRESSOR GENE PROTEIN IN GASTRIC ADENOCARCINOMA [J].

JOYPAUL, BV ;

HOPWOOD, D ;

NEWMAN, EL ;

QURESHI, S ;

GRANT, A ;

OGSTON, SA ;

LANE, DP ;

CUSCHIERI, A .

BRITISH JOURNAL OF CANCER, 1994, 69 (05) :943-946

[9]

KAWAI A, 1994, CANCER, V73, P2499, DOI 10.1002/1097-0142(19940515)73:10<2499::AID-CNCR2820731008>3.0.CO

[10]

2-G

← 1 2 3 4 →